Oncology

Immune Checkpoint Inhibitors and Survival Disparities by Health Insurance Coverage Among Patients with Metastatic Cancer

ICIs widened survival gaps between insured/uninsured advanced cancer patients despite improving outcomes across all insurance groups.

SC immunotherapy reduces chair time from 5-7 hours to 7 minutes but faces 45% reimbursement reduction and higher drug dose requirements.

Maecenas potenti ultrices, turpis eget turpis gravida.

There was an error trying to submit your form. Please try again.

This field is required.

There was an error trying to submit your form. Please try again.

Company